ZYLOPRIM Side Effects

6465833-9 | Device Related Infection, Disbacteriosis, Nosocomial Infection, Staphylococcal Infection, Stevens-johnson Syndrome, Toxic Epidermal Necrolysis, Wound Infection Staphylococcal
on Nov 18, 2009 Female patient from FRANCE , 51 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?), sleep disorder (What is sleep disorder?) and was treated with Zyloprim (View Usage). Patient experienced the following unwanted or unexpected effects: device related infection, disbacteriosis, nosocomial infection, staphylococcal infection (What is staphylococcal infection?), stevens-johnson syndrome, toxic epidermal necrolysis, wound infection staphylococcal. Zyloprim dosage: . During the same period patient was treated with BORTEZOMIB (1.3 Mg/m2; Iv) (View Bortezomib Review and Bortezomib Label ), THALIDOMIDE (200 Mg, Qd;) (View Thalidomide Review and Thalidomide Label ), DEXAMETHASONE TAB (40 Mg, Po) (View Dexamethasone Tab Review and Dexamethasone Tab Label ), DIFLUCAN (View Diflucan Review and Diflucan Label ), ZOLPIDEM (10 Mg;) (View Zolpidem Review and Zolpidem Label ), CATAPRES (View Catapres Review and Catapres Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), LOPRESSOR (View Lopressor Review and Lopressor Label ). Patient was hospitalized.

6145868-6 | Dyspnoea, Swelling
Patient was taking Zyloprim (View Usage). Patient had the following side effects: dyspnoea, swelling on Apr 06, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 150.0 lb, . Zyloprim dosage: 300mg Daily Oral. During the same period patient was treated with DYAZIDE (37.5 Mg/25 Mg Daily Oral) (View Dyazide Review and Dyazide Label ).

6104900-6 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Atelectasis, Bilirubin Conjugated Abnormal, Blood Chloride Increased, Blood Glucose Increased, Blood Pressure Systolic Increased, Blood Sodium Increased, Body Temperature Increased
Adverse event was reported on Feb 18, 2009 by a Male patient taking Zyloprim (View Usage) (Dosage: 100 Mg; Qd) was diagnosed with prophylaxis, tumour lysis syndrome, chronic lymphocytic leukaemia and. Location: UNITED STATES , 57 years of age, weighting 179.0 lb, After Zyloprim was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, atelectasis, bilirubin conjugated abnormal, blood chloride increased, blood glucose increased, blood pressure systolic increased, blood sodium increased, body temperature increased. During the same period patient was treated with TREANDA (200 Mg; Iv) (View Treanda Review and Treanda Label ). Patient was hospitalized.

6100461-6 | Condition Aggravated, Febrile Neutropenia, International Normalised Ratio Decreased, Pulmonary Embolism, Supraventricular Tachycardia, Therapeutic Response Decreased, Thrombocytopenia
on Feb 13, 2009 Male patient from UNITED STATES , 81 years of age, was diagnosed with disease recurrence, embolism and was treated with Zyloprim (View Usage). Patient experienced the following unwanted or unexpected effects: condition aggravated, febrile neutropenia, international normalised ratio decreased, pulmonary embolism (What is pulmonary embolism?), supraventricular tachycardia, therapeutic response decreased, thrombocytopenia. Zyloprim dosage: 300 Mg; Qd;. During the same period patient was treated with MERCAPTOPURINE (100 Mg; Qd; Po) (View Mercaptopurine Review and Mercaptopurine Label ), WARFARIN SODIUM (5 Mg; Qd;) (View Warfarin Sodium Review and Warfarin Sodium Label ), DILTIAZEM (View Diltiazem Review and Diltiazem Label ), MORPHINE SULFATE (View Morphine Sulfate Review and Morphine Sulfate Label ), OXYCODONE HCL (View Oxycodone Hcl Review and Oxycodone Hcl Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), DOCUSATE SODIUM (View Docusate Sodium Review and Docusate Sodium Label ). Patient was hospitalized.


5918343-9 | Abnormal Behaviour, Cognitive Disorder, Encephalitis Enteroviral, Speech Disorder
on Aug 28, 2008 Male patient from UNITED STATES , 70 years of age, was treated with Zyloprim (View Usage). Patient had the following side effects: abnormal behaviour, cognitive disorder, encephalitis enteroviral, speech disorder. Zyloprim dosage: . During the same period patient was treated with IRBESARTAN (View Irbesartan Review and Irbesartan Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ). Patient was hospitalized.

5875040-6 | Pain In Extremity, Pain Of Skin
Patient was taking Zyloprim (View Usage). After Zyloprim was administered, patient had the following side effects: pain in extremity, pain of skin on Aug 19, 2008 from UNITED STATES Additional patient health information: Male patient , 82 years of age, weighting 148.2 lb, was diagnosed with prophylaxis, tumour lysis syndrome and. Zyloprim dosage: 300 Mg;1x;po. During the same period patient was treated with RANITIDINE (View Ranitidine Review and Ranitidine Label ), LOVASTATIN (View Lovastatin Review and Lovastatin Label ), TERAZOSIN (View Terazosin Review and Terazosin Label ), TYLENOL WITH CODEIN #3 (View Tylenol With Codein #3 Review and Tylenol With Codein #3 Label ), ASCORBIC ACID (View Ascorbic Acid Review and Ascorbic Acid Label ), VITAMIN E (View Vitamin E Review and Vitamin E Label ), MEGACE (View Megace Review and Megace Label ). Patient was hospitalized.

5668423-0 | Dehydration, Gout, Leukocytoclastic Vasculitis, Serum Sickness
Adverse event was reported on Mar 04, 2008 by a Male patient taking Zyloprim (View Usage) (Dosage: 200 Mg; Bid; Po) was diagnosed with gout (What is gout?), pancreatic carcinoma and. Location: UNITED STATES , 72 years of age, weighting 78.00 lb, Patient experienced the following unwanted or unexpected effects: dehydration, gout (What is gout?), leukocytoclastic vasculitis, serum sickness. During the same period patient was treated with CETUXIMAB (768 Mg; X1 Wk; Iv; 480 Mg; Qwk; Iv) (View Cetuximab Review and Cetuximab Label ), OXALIPLATIN (100 Mg/m2; Q2wk; Iv) (View Oxaliplatin Review and Oxaliplatin Label ), GEMCITABINE (1000 Mg/m2; Q2wk; Iv) (View Gemcitabine Review and Gemcitabine Label ), INDOCIN (50 Mg; Bid; Po) (View Indocin Review and Indocin Label ). Patient was hospitalized.

5380930-7 | Completed Suicide, Depression, Personality Change
on Jun 27, 2007 Male patient from AUSTRALIA , 66 years of age, was treated with Zyloprim (View Usage). Patient had the following side effects: completed suicide, depression (What is depression?), personality change. Zyloprim dosage: Unk. During the same period patient was treated with COLGOUT (Unk) (View Colgout Review and Colgout Label ), ENAHEXAL (Unk) (View Enahexal Review and Enahexal Label ), VALIUM (Unk) (View Valium Review and Valium Label ), STILNOX CR (12.5 Mg) (View Stilnox Cr Review and Stilnox Cr Label ), TALOHEXAL (Unk) (View Talohexal Review and Talohexal Label ), INDAHEXAL (Unk) (View Indahexal Review and Indahexal Label ).

5120538-1 | Coma Hepatic, Hepatic Failure, Lobar Pneumonia, Pharyngolaryngeal Pain, Stevens-johnson Syndrome, Toxic Epidermal Necrolysis
on Feb 15, 2006 Male patient from JAPAN , 68 years of age, was treated with Zyloprim (View Usage). After Zyloprim was administered, patient had the following side effects: coma hepatic, hepatic failure, lobar pneumonia, pharyngolaryngeal pain, stevens-johnson syndrome, toxic epidermal necrolysis. Zyloprim dosage: Po. During the same period patient was treated with AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), AMINO ACIDS (View Amino Acids Review and Amino Acids Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), URSODEOXYCHOLIC ACID (View Ursodeoxycholic Acid Review and Ursodeoxycholic Acid Label ). Patient was hospitalized.

4939327-3 | Coma Hepatic, Hepatic Enzyme Increased, Hepatic Failure, Lobar Pneumonia, Lymphadenopathy, Stevens-johnson Syndrome, Toxic Epidermal Necrolysis
Patient was taking Zyloprim (View Usage). Patient experienced the following unwanted or unexpected effects: coma hepatic, hepatic enzyme increased, hepatic failure, lobar pneumonia, lymphadenopathy, stevens-johnson syndrome, toxic epidermal necrolysis on Feb 15, 2005 from JAPAN Additional patient health information: Male patient , 68 years of age, . Zyloprim dosage: Po. During the same period patient was treated with AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), AMINO ACIDS (View Amino Acids Review and Amino Acids Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), UROSODEOXYCHOLIC ACID (View Urosodeoxycholic Acid Review and Urosodeoxycholic Acid Label ). Patient was hospitalized.

4802961-5 | Blood Calcium Decreased, Blood Potassium Decreased, Pyrexia
Adverse event was reported on Oct 17, 2005 by a Male patient taking Zyloprim (View Usage) (Dosage: See Image) was diagnosed with burkitt's lymphoma, leukaemia and. Location: UNITED STATES , weighting 160.9 lb, Patient had the following side effects: blood calcium decreased, blood potassium decreased, pyrexia. During the same period patient was treated with CYCLOPHOSPHAMIDE (See Image) (View Cyclophosphamide Review and Cyclophosphamide Label ), PREDNISONE TAB (See Image) (View Prednisone Tab Review and Prednisone Tab Label ). Patient was hospitalized.

4802784-7 | Blood Test Abnormal, Liver Function Test Abnormal, Oedema Peripheral, Pyrexia, Rash, Skin Discolouration, Skin Exfoliation, Stevens-johnson Syndrome
on Oct 17, 2005 Male patient from UNITED STATES , 60 years of age, weighting 143.3 lb, was diagnosed with hyperuricaemia and was treated with Zyloprim (View Usage). After Zyloprim was administered, patient had the following side effects: blood test abnormal, liver function test abnormal, oedema peripheral, pyrexia, rash (What is rash?), skin discolouration, skin exfoliation, stevens-johnson syndrome. Zyloprim dosage: .

4731479-3 | Arterial Thrombosis, Catheter Related Complication, Cerebrovascular Accident, Convulsion, Procedural Complication
on Aug 01, 2005 Female patient from UNITED STATES , weighting 282.2 lb, was diagnosed with burkitt's lymphoma and was treated with Zyloprim (View Usage). Patient experienced the following unwanted or unexpected effects: arterial thrombosis, catheter related complication, cerebrovascular accident, convulsion, procedural complication. Zyloprim dosage: See Image. During the same period patient was treated with CYCLOPHOSPHAMIDE (See Image) (View Cyclophosphamide Review and Cyclophosphamide Label ), PREDNISONE (See Image) (View Prednisone Review and Prednisone Label ). Patient was hospitalized.

4710793-1 | Aspergillosis, Culture Positive, Haemoptysis
Patient was taking Zyloprim (View Usage). Patient had the following side effects: aspergillosis, culture positive, haemoptysis on Jul 06, 2005 from UNITED STATES Additional patient health information: Female patient , weighting 243.6 lb, was diagnosed with burkitt's lymphoma, leukaemia and. Zyloprim dosage: 300 Mg Po Qd For 14 Days. During the same period patient was treated with CYCLOPHOSPHAMIDE (200 Mg/m2 Iv Over 5-15 Min Qd On Days 1-5.) (View Cyclophosphamide Review and Cyclophosphamide Label ), PREDNISONE (60 Mg/m2 Po Qd On Days 1-7) (View Prednisone Review and Prednisone Label ).

4710769-4 | Blood Creatine Increased
Adverse event was reported on Jul 06, 2005 by a Female patient taking Zyloprim (View Usage) (Dosage: 300 Mg Po Qd For 14 Days) was diagnosed with burkitt's lymphoma, leukaemia and. Location: UNITED STATES , weighting 243.6 lb, After Zyloprim was administered, patient had the following side effects: blood creatine increased. During the same period patient was treated with CYCLOPHOSPHAMIDE (200 Mg/m2 Iv Over 5-15 Min Qd On Days 1-5) (View Cyclophosphamide Review and Cyclophosphamide Label ), PREDNISONE (60 Mg/m2 Po Qd On Days 1-7) (View Prednisone Review and Prednisone Label ).

4641733-1 | Aplastic Anaemia, Bacterial Sepsis, Blood Bilirubin Increased, Cardiomegaly, Clostridial Infection, Enterococcal Infection, Fungal Infection, Gram Stain Negative
on Apr 04, 2005 Male patient from , 65 years of age, was diagnosed with gout (What is gout?) and was treated with Zyloprim (View Usage). Patient experienced the following unwanted or unexpected effects: aplastic anaemia, bacterial sepsis, blood bilirubin increased, cardiomegaly, clostridial infection, enterococcal infection, fungal infection (What is fungal infection?), gram stain negative. Zyloprim dosage: 300 Mg; Qd; Po. During the same period patient was treated with ATGAM (View Atgam Review and Atgam Label ), IMMUNOGLOBULIN (View Immunoglobulin Review and Immunoglobulin Label ), CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ). Patient was hospitalized.

4608617-6 | Blood Glucose Increased
on Mar 11, 2005 Female patient from , weighting 243.6 lb, was treated with Zyloprim (View Usage). Patient had the following side effects: blood glucose increased. Zyloprim dosage: 300 Mg Po Qd For 14 Days. During the same period patient was treated with CYCLOPHOSPHAMIDE (200 Mg/m2 Iv Over 5-15 Min Qd On Days 1-5) (View Cyclophosphamide Review and Cyclophosphamide Label ), PREDNISONE (60 Mg/m2 Po Qd Days 1-7) (View Prednisone Review and Prednisone Label ).

4604072-0 | Drooling, Dysphagia, Stevens-johnson Syndrome
Patient was taking Zyloprim (View Usage). After Zyloprim was administered, patient had the following side effects: drooling, dysphagia, stevens-johnson syndrome on Mar 09, 2005 from Additional patient health information: Female patient , 76 years of age, weighting 122.1 lb, was diagnosed with gout (What is gout?) and. Zyloprim dosage: . Patient was hospitalized.

4579252-3 | Dyspnoea, Epistaxis, Haematuria, Oxygen Saturation Decreased, Pulmonary Embolism, Tachycardia, Thrombocytopenia
Adverse event was reported on Feb 10, 2005 by a Male patient taking Zyloprim (View Usage) (Dosage: 300 Mg Po Qd For 14 Days) . Location: , weighting 271.2 lb, Patient experienced the following unwanted or unexpected effects: dyspnoea, epistaxis, haematuria, oxygen saturation decreased, pulmonary embolism (What is pulmonary embolism?), tachycardia, thrombocytopenia. During the same period patient was treated with CYCLOPHOSPHAMIDE (200 Mg /m2 Iv Over 5-15 Min Qd On Days 1-5) (View Cyclophosphamide Review and Cyclophosphamide Label ), PREDNISONE (60 Mg/m2 Po Qd On Days 1-7) (View Prednisone Review and Prednisone Label ).

4579251-1 | Dysphagia, Mucosal Inflammation, Neutropenia, Pharyngolaryngeal Pain, Pyrexia
on Feb 10, 2005 Male patient from , weighting 202.8 lb, was treated with Zyloprim (View Usage). Patient had the following side effects: dysphagia, mucosal inflammation, neutropenia, pharyngolaryngeal pain, pyrexia. Zyloprim dosage: 300 Mg Po Qd For 14 Days. During the same period patient was treated with CYCLOPHOSPHAMIDE (200 Mg /m2 Iv Over 5-15 Min Qd On Days 1-5) (View Cyclophosphamide Review and Cyclophosphamide Label ), PREDNISONE (60 Mg/m2 Po Qd On Days 1-7) (View Prednisone Review and Prednisone Label ). Patient was hospitalized.